SCHEMBL52596

SCHEMBL52596

Cc1nnc(C(=O)Cl)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3327764 0.98 EPHX2 (0.33)
SCHEMBL11596230 0.82 PTPN1 (0.30)
SCHEMBL13275068 0.80 KDM4E (0.38)
SCHEMBL185561 0.78
Potassium SCHEMBL834916 0.76 PTPN1 (0.41)
SCHEMBL22436525 0.76 PTPN1 (0.41)
SCHEMBL3355222 0.76
Hydrochloric Acid SCHEMBL22436543 0.76 PTPN1 (0.41)
SCHEMBL7374599 0.74 ALDH1A1 (0.42)
Potassium Ion SCHEMBL52283 0.74 KDM4E (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12404284-B2 Spirocyclic inhibitors of hepatitis B virus OSPEDALE SAN RAFFAELE S.R.L. (IT) 2025-09-02 US disclosed
EP-4494709-A2 SPIROCYCLIC INHIBITORS OF HEPATITIS B VIRUS Ospedale San Raffaele S.r.l. (IT) 2025-01-22 EP disclosed
US-20240368150-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER HOFFMANN-LA ROCHE INC. (US) 2024-11-07 US disclosed
EP-4103567-B1 SPIROCYCLIC INHIBITORS OF HEPATITIS B VIRUS OSPEDALE SAN RAFFAELE SRL (IT) 2024-10-23 EP disclosed
EP-3833672-B1 TRICYCLIC INHIBITORS OF HEPATITIS B VIRUS OSPEDALE SAN RAFFAELE SRL (IT) 2024-09-18 EP disclosed
CN-113272309-B Tricyclic inhibitors of hepatitis b virus 圣拉斐尔医院有限公司 2024-02-23 CN disclosed
CN-117447375-A Guanidine compound, preparation method and application thereof 中国医学科学院药物研究所 2024-01-26 CN disclosed
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 EP disclosed
CN-116964048-A Bicyclic tetrahydroazepine derivatives for the treatment of cancer 豪夫迈·罗氏有限公司 2023-10-27 CN disclosed
US-20230151027-A1 SPIROCYCLIC INHIBITORS OF HEPATITIS B VIRUS OSPEDALE SAN RAFFAELE S.R.L. (IT) 2023-05-18 US disclosed
US-20070292504-A1 Pharmaceutical formulation containing a release rate controlling composition MERCK SHARP & DOHME LLC 2007-12-20 US disclosed
US-20070259894-A1 Use of Atazanavir for Improving the Pharmacokinetics of Drugs Metabolized by Ugt1a1 MERCK SHARP & DOHME CORP. 2007-11-08 US disclosed
US-20070259894-A1 Use of Atazanavir for Improving the Pharmacokinetics of Drugs Metabolized by Ugt1a1 MERCK SHARP & DOHME CORP. 2007-11-08 US disclosed
WO-2007087188-A2 TASTE-MASKED TABLETS AND GRANULES MERCK & CO., INC. (US) 2007-08-02 WO disclosed
WO-2006060731-A2 USE OF ATAZANAVIR FOR IMPROVING THE PHARMACOKINETICS OF DRUGS METABOLIZED BY UGT1A1 MERCK & CO., INC. (US) 2006-06-08 WO disclosed
US-4326065-A PLASTICS, VARNISHES, POLYESTERS EASTMAN KODAK COMPANY (US) 1982-04-20 US disclosed
US-4251433-A BENZOTRIAZOLE DERIVATIVES; FOR POLYMERS EASTMAN KODAK COMPANY (US) 1981-02-17 US disclosed
US-4236013-A ADDITIVES FOR POLYMERS EASTMAN KODAK COMPANY (US) 1980-11-25 US disclosed
US-4137235-A ULTRAVIOLET STABILIZERS IN POLYMERIC COMPOSITIONS EASTMAN KODAK COMPANY (US) 1979-01-30 US disclosed
US-4116928-A Heterocylic ester, ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1978-09-26 US disclosed